|
HS Code |
351990 |
| Chemical Name | 2-Bromo-5-Phenyl-1,3,4-Oxadiazole |
| Molecular Formula | C8H5BrN2O |
| Cas Number | 31423-66-6 |
| Appearance | White to off-white solid |
| Melting Point | 124-126 °C |
| Solubility | Slightly soluble in organic solvents |
| Purity | Typically ≥98% |
| Smiles | C1=CC=C(C=C1)C2=NN=C(O2)Br |
| Inchi | InChI=1S/C8H5BrN2O/c9-8-11-10-7(12-8)6-4-2-1-3-5-6/h1-5H |
As an accredited 2-Bromo-5-Phenyl-1,3,4-Oxadiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Bromo-5-Phenyl-1,3,4-Oxadiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Lab benches and industrial shelves carry many chemicals, but only a select few draw repeated interest from pharmaceutical and research communities year after year. 2-Bromo-5-Phenyl-1,3,4-Oxadiazole is one of those compounds that doesn’t just sit quietly in a bottle; it helps push progress across sectors where precision reactions matter. Chemists who work with small building blocks know just how crucial it is to start with a backbone that supports both stability and reactivity. Speaking from years at the bench, finding a heterocycle that reacts smoothly, gives high yields and opens doors for further modification never really gets old. The oxadiazole ring—especially this bromo-phenyl substituted version—brings those qualities front and center.
The molecule itself stands out immediately for its five-membered oxadiazole core, flanked by a bromine atom and a phenyl group. Plenty of chemists may shrug when looking at another aromatic ring at first glance, but the haloarene aspect throws another layer into the mix. Bromine, with its larger size and polarizability, often gets leveraged for its ability to activate aromatic systems, shifting the reactivity of the ring in ways that make selective cross-couplings or nucleophilic substitutions much more straightforward. In my own practice, what stuck out about this compound is how it balances electron-withdrawing and donating groups to create a “just right” window for a series of organic transformations. Jumping from theory to practical reaction planning, reliable reactivity shapes every step.
Anyone involved in medicinal chemistry or advanced materials work eventually encounters the delicate balance between building molecular complexity and maintaining functional group compatibility. The model of 2-Bromo-5-Phenyl-1,3,4-Oxadiazole lands solidly in the small-molecule intermediate category, yet its potential stretches farther than that label suggests. Once you look at the specifications—a solid crystalline form, white to off-white with good purity and stability—there’s a sense of trust that carries through from shipment to storage to application. Having handled a lot of intermediates that degrade or turn sticky, these tangible features really mean something when scaling up or running multiple parallel reactions.
Specifications often tell you only part of the story, but chemists grow to respect products that deliver clean reaction outcomes and don’t introduce unnecessary variables. 2-Bromo-5-Phenyl-1,3,4-Oxadiazole typically offers melting points in a stable range, solubility in standard polar organic solvents like DMF, DMSO, or acetonitrile, and compatibility with both traditional and more modern synthetic methodologies. There’s less worry about hygroscopicity or unwanted side reactions compared with other heterocycles—practical perks that lead to fewer headaches down the line.
No scientist wants to waste time optimizing reaction conditions because of an unreliable starting material. With this oxadiazole derivative, applications often begin with Suzuki, Sonogashira, or Buchwald–Hartwig cross-coupling reactions. Having a bromo group in this position opens a straightforward route for arylation or amination, which means it slots right into custom drug design and development projects where scaffold hopping or lead optimization calls for a new twist on established frameworks. On more than one occasion, I’ve used it as a coupling partner to expand a pharmaceutical candidate’s aromatic landscape, achieving combinations that just don’t work with less reactive or less stable analogs.
Synthetic chemists working on agrochemicals or advanced organic materials have found that this molecule’s unique substitution pattern allows for tunable interactions with other aromatic and heterocyclic partners. Its rigid backbone supports efforts to construct more diverse libraries of compounds—each one a new avenue for biological screening or material property testing. Unlike some less stable oxadiazole derivatives, this product stands up to the demands of solvent, temperature, and workload, leading to higher confidence in reproducibility and less troubleshooting.
The field of heterocyclic chemistry spans a staggering number of options, so standing out means more than just adding another bromine here or a phenyl group there. Comparing this compound with related intermediates paints a clear picture: some 1,3,4-oxadiazoles swap bromine for chlorine or iodine, while others feature methyl, alkoxy, or even nitro groups on the aromatic ring. In daily practice, the differences matter. For example, the bromine atom’s size and electron-withdrawing properties allow more predictable and often milder reaction conditions than the tougher, sometimes less selective chlorides. Using iodo analogs can introduce safety and cost issues, plus iodides tend to be more reactive than necessary for typical pharmaceutical-scale coupling work. It circles back to pragmatism—the chemistry that gets results with minimal fuss tends to earn repeat use.
From a materials perspective, other oxadiazoles or pyrazoles may lack the balance of reactivity and stability this compound brings. Plenty of aromatic heterocycles behave nicely in the flask but perform poorly in further derivatization or scale-up. For chemists racing to meet project milestones, those shortcomings add up. Over-reactions, poor recoveries, or decomposition complicate life in ways that aren’t always evident in sales catalogs. People working in both startup labs and established companies have come to rely on this compound for its consistency—batch to batch, the handling remains familiar and the outcomes reproducible.
Quality control in fine chemicals means more than just ticking boxes on a data sheet. In my experience, how a product behaves in a reaction tells its own story. 2-Bromo-5-Phenyl-1,3,4-Oxadiazole’s typical purity levels—frequently above 98%—make a tangible difference in downstream chemistry. Rough spots from residual unidentified impurities often turn a standard step into a time-consuming optimization, especially in complex multi-step syntheses. With this compound, lab teams can plan ambitious couplings, substitutions, or ring closures without spending extra resources troubleshooting results that stem from the starting material. That reliability translates into less downtime and fewer surprises on analytical runs.
Traceability and transparent marketing also matter. I’ve purchased and tested plenty of products both from domestic and international markets. The difference in quality from a reputable supplier often appears before opening the bottle: clean, professional packaging, a certificate of analysis listing not only purity but also results from detailed chromatographic and spectral tests. Those elements give purchasing managers and bench scientists peace of mind. The compound’s reputation travels with it, especially for grant-funded projects or collaborations where every reagent needs to perform as claimed.
Medicinal chemists don’t only care about purity and reactivity values on a certificate. They look for compounds that help them build new molecular scaffolds efficiently and safely. In my past collaborations with drug discovery teams, the strength of 2-Bromo-5-Phenyl-1,3,4-Oxadiazole has shown through when both lead optimization and structure-activity relationship (SAR) explorations are on the docket. Researchers appreciate that it avoids the batch-to-batch headaches and unpredictable degradation sometimes seen with similar intermediates. This directly supports the relentless pace and tight deadlines that come with pharmaceutical development cycles.
Beyond pharma, researchers in advanced polymers and organic electronics tap into this compound’s aromatic rigidity and consistent substitution pattern to build sensors, OLED materials, or molecular wires. The strong C-Br bond and aromatic ring make it possible to fine-tune electronic properties in new molecules—opening doors for POC devices or experimental conductive materials. As industries start requiring higher performance in smaller, more robust components, reliability in the underlying chemistry increases in importance.
A common frustration in chemical procurement is unclear origin, variable batch quality, or insufficient analytical support on delivered products. Poor documentation and vague specifications burn up time that would be better spent generating data or running reactions. With 2-Bromo-5-Phenyl-1,3,4-Oxadiazole from reputable sources, clear labeling, detailed certificates of analysis, and transparent documentation have become a norm rather than an exception. For anyone running regulated syntheses or preparing for scale-up, those differences are far from trivial.
Supply chain issues, especially since the disruptions of recent years, have made a stable source of high-quality intermediates more valuable than before. Some chemists may try to synthesize similar compounds in-house to save costs, but yield loss, increased purification steps, and inexperience with hazardous halogenating agents can create more risks than benefits. Investing in a stable supply and establishing direct communication with reliable chemical providers brings rewards not just in time saved, but also in lab safety and regulatory compliance.
Every lab has its way of stretching a grant dollar, but smart procurement and inventory management can make all the difference when it comes to specialty reagents. With 2-Bromo-5-Phenyl-1,3,4-Oxadiazole, buying in amounts tailored to project scale helps minimize waste and storage concerns. The compound’s stability means that even over longer projects or extended storage, physical and chemical properties stay intact; that consistency means that a bottle opened at the start of a project will give the same performance at the end. In my own work, that’s prevented more than a few last-minute scrambles to troubleshoot or re-do key steps before shipment or testing deadlines.
For researchers pushing into new territory with complex couplings or late-stage diversification, using a well-characterized intermediate removes doubt when interpreting analytical data. Consistent retention times, clean NMR peaks, and known impurity profiles increase confidence at every stage. In group meetings, fewer questions and caveats about starting materials help keep focus squarely on discovering new structure-function relationships, rather than side-tracking into quality control debates.
Many research projects now face growing pressure to adopt greener, safer methods. The robust nature of 2-Bromo-5-Phenyl-1,3,4-Oxadiazole fits well with this trend. Unlike some halogenated intermediates that require strictly anhydrous, oxygen-free conditions or pose particular handling hazards, this product maintains performance under more forgiving laboratory conditions. This opens up the possibility of running reactions with less specialized equipment, saving energy and reducing the technical barrier for junior chemists. Cleaner transformations also mean less investment in time-intensive purification, which not only saves solvent and energy but also supports environmental goals.
Progress in sustainable chemistry can feel slow when daily project demands dominate. Being able to select reliable, well-characterized intermediates makes it easier to switch to greener methodologies, since known reactivity profiles speed up method validation and scale-up. When deploying catalytic cross-couplings or direct arylations, the ability to predict and reproduce clean product formation means fewer pilot runs, less waste, and increased safety—all without compromising project outcomes.
As someone who’s spent a fair stretch jumping between academic labs and industry, trust built on evidence matters more than ever in today’s chemical world. The standard for advanced intermediates continues to rise: complete product data, open channels of support, and a culture of quality assurance stand as non-negotiable. 2-Bromo-5-Phenyl-1,3,4-Oxadiazole’s established presence in the literature adds to its reputation, with numerous peer-reviewed articles outlining synthetic applications, downstream transformations, and even computational studies examining its electronic properties.
A quick review of literature highlights real use cases: it’s been employed in synthesizing anti-cancer scaffolds, modifying advanced dyes, and as a platform for studying new reaction mechanisms. These published outcomes reduce anxiety about unknowns and help guide less experienced chemists through the process, from planning to execution. The value of open-access experimental details can hardly be overstated; shared methodologies and troubleshooting records help ensure ongoing improvements and support the next generation of synthetic strategies.
Recent years brought disruption to nearly every supply chain, and the fine chemicals sector hasn’t been immune. Projects that once took weeks could be delayed for months due to lack of reliable intermediates. In a climate of uncertainty, consistency and transparency matter. Researchers have returned to products with a reliable track record, robust analytical support, and demonstrated compatibility with a wide range of synthetic procedures. 2-Bromo-5-Phenyl-1,3,4-Oxadiazole stands out here. Having a steady, trusted supply means fewer false starts, more accurate project forecasting, and higher morale among chemists whose progress depends on steady access to key reagents.
In my own networks, I’ve seen how fast-response technical support, open documentation, and community-shared best practices build not only technical value but also professional trust. Companies that provide detailed analysis reports, quick reordering options, and flexible shipping give labs the confidence needed to say “yes” to riskier, more innovative research lines. The molecular reliability of 2-Bromo-5-Phenyl-1,3,4-Oxadiazole strengthens this ecosystem, where every part of the supply process—from batch production through customer support—counts for scientific credibility.
Despite advances in the chemical manufacturing sector, gaps still exist around transparency, scalability, and global access. For 2-Bromo-5-Phenyl-1,3,4-Oxadiazole, the best solutions come through partnerships that combine robust manufacturing with responsive customer support and technical transparency. Larger suppliers have improved analytical packages, offering both advanced chromatographic and spectroscopic analysis, but smaller specialty producers can also add value by building strong lines of communication with researchers. Access to live support, searchable application databases, and simple online purchasing has helped bridge the gap between development and research labs across continents.
For labs aiming to maximize impact, the solution lies in treating each purchase as a step in a larger workflow. Streamlining procurement, leveraging collective feedback on batch quality, and investing in long-term relationships with suppliers all contribute to smoother progress. For those tackling novel molecular architectures or scaling up pilot processes, a well-chosen intermediate like this one cuts risk and builds project momentum.
2-Bromo-5-Phenyl-1,3,4-Oxadiazole is more than a static bottle on the shelf. Its reliability supports the push for new therapeutics, greener processes, and advanced materials. The realities of the lab—tight timelines, competing priorities, and pressure for innovation—demand products that deliver on every promise, from purity and consistency to availability and safety. Based on years of experience and industry-wide reports, this compound continues proving its worth not only as a cornerstone intermediate but also as a driver of new discovery. As research keeps evolving, compounds that blend trusted performance with practical handling will remain part of the backbone that keeps science moving forward.